Influenza B virus (ATCC® VR-787)

Classification: Orthomyxoviridae, Influenzavirus B  /  Product Format: frozen

Classification Orthomyxoviridae, Influenzavirus B
Agent Influenza B virus
Strain B/R5
Applications
Influenza Research
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Isolation
Recombinant of B/Hong Kong/8/73 (ATCC VR-792) and influenza B/Brigit (ATCC VR-786)
Product Format frozen
Storage Conditions -60°C or colder
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Comments
Influenza strain B/Hong Kong/8/73 antigenicity, negative hemagglutinin thermosensitivity at 60C.
Effect on Host
Yes, in vitro effects: Hemagglutination activity
HA activity
Recommended Host
8 to 11 day chicken embryo, i.a. inoculation

Recommended Host:  CE (8-11 days, i.a.).

Host Range: CE

Host Range: CE

chicken embryo
Growth Conditions
Temperature: 37.0°C
Duration: 1-4 days
Effect on Host
Yes, in vitro effects: Hemagglutination activity
HA activity
Name of Depositor R.I.T. - Recherche et Industrie Therapeutiques
U.S. Patent
U.S. Patent Number
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Source
Recombinant of B/Hong Kong/8/73 (ATCC VR-792) and influenza B/Brigit (ATCC VR-786)
References

Peetermans J, et al. Live influenza type B virus vaccines and preparation thereof. US Patent 3,962,423 dated Jun 8 1976